Prof. Dr. Elif KüpeliProf. Dr. Elif KüpeliChest Diseases SpecialistProf. Dr. Elif Küpeli+90 539 716 24 01REVIEWSMENU
Prof. Dr. Elif Küpeli+90 539 716 24 01

Should COPD Patients Get the Flu and Pneumonia Vaccines?

Should COPD Patients Get the Flu and Pneumonia Vaccines?

What is COPD?

COPD (Chronic Obstructive Pulmonary Disease) is a progressive respiratory disease usually associated with smoking. However, COPD can also develop in individuals who have never smoked.

Causes of COPD

The primary causes of COPD include:

  • Smoking: The most significant risk factor. Smoking introduces chemicals that damage the lungs, leading to chronic inflammation, airway narrowing, and lung tissue damage over time.
  • Air Pollution: Environmental pollutants, industrial fumes, dust, and chemicals can also increase the risk of COPD.
  • Genetic Factors: A genetic predisposition can make some individuals more susceptible to developing COPD than others.
  • Occupational Exposure: Exposure to dust and chemicals in certain occupations can contribute to the development of COPD.
  • Recurring Respiratory Infections: Frequent respiratory infections, especially during childhood, can increase the risk of developing COPD.

Treatment for COPD focuses on managing symptoms, slowing disease progression, and improving quality of life. Treatments may include quitting smoking, medications, breathing exercises, oxygen therapy, and sometimes surgical interventions.

Should COPD Patients Get the Flu and Pneumonia Vaccines?

People with COPD are at increased risk for respiratory infections due to compromised lung function. Both flu and pneumonia infections can lead to serious complications in individuals with weakened respiratory systems. For this reason, it is generally recommended that individuals with COPD receive both the influenza (flu) vaccine and the pneumococcal (pneumonia) vaccine.

What is the Influenza (Flu) Vaccine?

The flu vaccine provides protection against the influenza virus. The flu is a contagious respiratory illness caused by a virus that spreads in seasonal outbreaks. The flu vaccine can reduce the severity of the illness and lower the risk of complications.

The flu vaccine is generally recommended for the following groups:

High-Risk Groups:

  • Individuals aged 65 and older
  • People with chronic health conditions (such as heart disease, kidney disease, diabetes, and chronic lung conditions like COPD)
  • Those with weakened immune systems (such as organ transplant recipients, individuals taking immunosuppressive medications, and cancer patients)
  • Pregnant women

Healthcare Workers and Caregivers: Those working in healthcare and caregiving settings are advised to get the flu vaccine to reduce the risk of spreading the illness.

School-Age Children: Children should receive the flu vaccine as the flu can lead to serious complications in young children.

Travelers During Flu Season: Those traveling during the flu season may consider getting the flu vaccine to reduce their risk.

The flu vaccine is typically updated annually because the influenza virus constantly changes. The vaccine contains one or more strains of the influenza virus to boost the immune system and provide protection.

Getting the annual flu vaccine is important for individuals with COPD, as influenza can worsen COPD symptoms, cause respiratory distress, and lead to potentially serious complications.

What is the Pneumococcal Vaccine?

The pneumococcal vaccine is designed to protect against infections caused by the bacteria Streptococcus pneumoniae, commonly known as pneumococcus. This bacteria can cause a variety of diseases, including pneumonia, meningitis, and bloodstream infections. Pneumococcal vaccines reduce the risk of serious illness and complications by preparing the immune system to recognize and fight this bacteria. People with COPD are prone to lower respiratory tract infections and should receive the pneumonia vaccine.

There are two types of pneumococcal vaccines - Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23). Each vaccine protects against different strains of the Streptococcus pneumoniae bacteria.

Pneumococcal Conjugate Vaccine (PCV13): Protects against 13 strains of Streptococcus pneumoniae.

Pneumococcal Polysaccharide Vaccine (PPSV23): Protects against 23 strains of Streptococcus pneumoniae.

Who Should Get Pneumococcal Vaccine?

  • Adults age 65 and older are generally recommended to get both types of pneumococcal vaccine.
  • People with chronic conditions such as diabetes, heart disease, lung disease (including COPD),and chronic renal failure.
  • People without a spleen or asplenia.
  • Residents of long-term care facilities.
  • People with a cerebrospinal fluid leak or cochlear implant.
  • People with sickle cell disease, HIV infection, or a suppressed immune system (such as cancer patients).
  • People undergoing radiation therapy or an organ transplant.
  • People with alcohol dependence.

 

Altta Yatan Kronik Hastalığı Olmayan Sağlıklı 65 Yaş ve Üzeri Kişiler için Pnömokok Aşılama Şeması:

Pnömokok Aşılama Şeması

Both conjugate and polysaccharide vaccines are recommended for adults.

  • The polysaccharide vaccine can be repeated up to three times, with a five-year interval between doses, with the third booster recommended after age 65.
  • The conjugate vaccine is administered as a single dose in adults.
    For adults not in a high-risk group, the two pneumococcal vaccines (preferably PCV13 first, followed by PPSV23) should be spaced at least one year apart.
  • For adults aged 65 and over, it is recommended to administer the conjugate vaccine (PCV13) first, followed by the polysaccharide vaccine (PPSV23) one year later.
  • For high-risk individuals aged 19-64 and over 65 with immunodeficiency, asplenia (absence of a spleen),cerebrospinal fluid (CSF) leaks, or cochlear implants, PCV13 should be administered first, followed by PPSV23 after eight weeks, or PPSV23 first, followed by PCV13 at least one year later.

Side Effects of the Pneumococcal Vaccine: Pain, redness at the injection site, moderate and temporary fever, headache, fatigue, loss of appetite, myalgia, and urticaria are potential side effects that may occur after vaccination.

Update Date: 21.02.2024
Elif Küpeli, MD, Professor
Editor
Prof. Dr. Elif Küpeli
Chest Diseases Specialist
The content of this page is for informational purposes only.
Please consult your physician for diagnosis and treatment.
CONTACT FORM
AFFILIATED INSTITUTIONS
Our clinic has agreements with the following institutions or private insurance companies. For institutions or private insurances with which we do not have an agreement, we issue invoices based on the TTB (Turkish Medical Association) price list. Patients can then collect the amount they have paid from their insurance or institutions.
  1. axa-sigorta
  2. anadolu sigorta
  3. iş bankası
  4. ziraat bankası
  5. garanti bankası
Elif Küpeli, MD, ProfessorProf. Dr. Elif KüpeliChest Diseases Specialist
+90 539 716 24 01